{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:52:57Z","timestamp":1780685577220,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004618","name":"Universit\u00e9 de Bourgogne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.dld.2021.05.028","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T07:01:24Z","timestamp":1624777284000},"page":"1492-1498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences"],"prefix":"10.1016","volume":"53","author":[{"given":"Im\u00e8ne","family":"Marref","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Romain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Jooste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9211-4707","authenticated-orcid":false,"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.05.028_bib0001","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.dld.2021.05.028_bib0002","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","article-title":"Changing patterns of anal canal carcinoma in the United States","volume":"31","author":"Nelson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0003","first-page":"e96","article-title":"Rising incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016","volume":"18","author":"Guren","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.dld.2021.05.028_bib0004","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.dld.2021.05.028_bib0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CEJ.0000000000000163","article-title":"Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study","volume":"25","author":"Bouvier","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.dld.2021.05.028_bib0006","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2021.05.028_bib0007","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02588101","article-title":"Radiation therapy in the management of epidermoid carcinoma of the anal region","volume":"17","author":"Papillon","year":"1974","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2021.05.028_bib0008","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR anal cancer trial working party. UK Co-ordinating committee on cancer research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2021.05.028_bib0009","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0010","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0011","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(17)30071-2","article-title":"Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial","volume":"18","author":"Glynne-Jones","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0012","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.dld.2021.05.028_bib0013","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1002\/sim.3064","article-title":"Flexible parametric models for relative survival, with application in coronary heart disease","volume":"26","author":"Nelson","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.dld.2021.05.028_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"issue":"Suppl 3","key":"10.1016\/j.dld.2021.05.028_bib0015","doi-asserted-by":"crossref","first-page":"iii10","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0016","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.dld.2017.05.011","article-title":"Anal cancer: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)","volume":"49","author":"Moureau-Zabotto","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.05.028_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.critrevonc.2016.03.001","article-title":"Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers","volume":"101","author":"Delhorme","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.dld.2021.05.028_bib0018","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.dld.2014.01.004","article-title":"Results of age-dependent anal canal cancer treatment: a single centre retrospective study","volume":"46","author":"Claren","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.05.028_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/COC.0b013e31827e52a3","article-title":"Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity","volume":"37","author":"Mitchell","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s11605-009-0870-2","article-title":"Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging","volume":"13","author":"Otto","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.dld.2021.05.028_bib0021","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S1470-2045(17)30456-4","article-title":"Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study","volume":"18","author":"Sekhar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0022","article-title":"Anal cancer: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP)","volume":"49","author":"Moureau-Zabotto","year":"2019","journal-title":"Th\u00e9saurus Natl Canc\u00e9rol Dig"},{"key":"10.1016\/j.dld.2021.05.028_bib0023","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1996.14.12.3121","article-title":"Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients","volume":"14","author":"Doci","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0167-8140(97)00192-8","article-title":"Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients","volume":"46","author":"Gerard","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0167-8140(93)90076-K","article-title":"Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin","volume":"27","author":"Rich","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0026","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2021.05.028_bib0027","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2014.10.002","article-title":"Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines","volume":"113","author":"Leon","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0028","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.dld.2021.05.028_bib0029","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.bjc.6605605","article-title":"Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)","volume":"102","author":"Northover","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.dld.2021.05.028_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2021.05.028_bib0031","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.ejca.2011.10.038","article-title":"Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002","volume":"48","author":"Faivre","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.dld.2021.05.028_bib0032","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/codi.12222","article-title":"Outcome of salvage surgery for anal squamous cell carcinoma","volume":"15","author":"Harris","year":"2013","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.dld.2021.05.028_bib0033","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2014.11.021","article-title":"Reirradiation of locally recurrent rectal cancer: a systematic review","volume":"113","author":"Guren","year":"2014","journal-title":"Radiother Oncol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821002796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821002796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:45Z","timestamp":1761625125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821002796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1590865821002796"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.05.028","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of anus squamous cell carcinoma. Management of anus squamous cell carcinoma and recurrences","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}